Triveni Bio

Triveni Bio is a biotechnology company. The company provides genetics-based precision medicine approaches and develops functional antibodies for the treatment of I&I disorders. Its lead antibody program (TRIV-509) targets kallikrein 5 and 7 (KLK5/7), which are promising targets for the treatment of atopic dermatitis, asthma, and other I&I indications.